|
FDA批准使用Vascepa降低某些成年患者群体中发生心血管...
2019.12.13
FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups
The U.S. Food and Drug Administration today approved the use of Vascepa (icosapent ethyl) as an adjunctive (secondary) therapy to reduce the risk of ca...
|
